Related Experiment Video

Updated: Jun 19, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Hepatitis B virus inhibition in mice by lentiviral vector mediated short hairpin RNA

Lei Deng1, Guoqiang Li, Lisen Xi

  • 1Liver Transplantation Center of the First Affiliated Hospital, Nanjing Medical University, 300 Guangzhou Road, Nanjing, Jiangsu 210029, PR China. szwam@nuaa.edu.cn

BMC Gastroenterology
|October 7, 2009
PubMed
Abstract

Insights

A novel lentivirus-based RNA interference (RNAi) system effectively suppressed hepatitis B virus (HBV) replication in a mouse model. This RNAi therapy significantly reduced HBV DNA and antigens, offering a promising new treatment strategy for chronic HBV infection.

Area of Science:

  • Virology
  • Gene Therapy
  • Molecular Biology

Background:

  • Chronic hepatitis B virus (HBV) infection leads to cirrhosis and liver cancer.
  • Current therapies face challenges with low efficacy and drug resistance.
  • RNA interference (RNAi) presents a novel therapeutic approach for HBV by targeting virus-specific genes.

Purpose of the Study:

  • To develop and evaluate a lentivirus-based RNA interference (RNAi) system for suppressing HBV replication.
  • To assess the efficacy of delivering HBV-specific short hairpin RNA (shRNA) using lentiviral vectors in a mouse model.

Main Methods:

  • Development of a lentivirus system to deliver HBV-specific shRNA.
  • Analysis of hepatitis B surface antigen (HBsAg) and hepatitis B e antigen (HBeAg) using ELISA.
  • Detection of hepatitis B core antigen (HBcAg) and HBsAg in liver tissues via immunohistochemistry.
  • Quantification of HBV DNA and mRNA using FQ-PCR and real-time PCR.

Main Results:

  • Lentiviral delivery of HBV shRNA induced an RNAi response, significantly reducing HBsAg (89%) and HBeAg in mouse serum.
  • Immunohistochemical analysis showed substantial reduction of HBcAg and HBsAg in liver tissues.
  • Lentiviral shRNA significantly suppressed HBV mRNA and DNA synthesis compared to controls.

Conclusions:

  • Lentivirus-based RNAi is effective in suppressing HBV replication in vivo.
  • This approach holds potential as a therapeutic strategy for treating HBV infection.
  • The developed system may also be applicable to other viral infections.

More Related Videos

Lentiviral Vector Preparation for Efficient Gene and MicroRNA Modulation of Peritoneal Cavity Tissue-Resident Macrophages In Vivo in Mice06:33

Lentiviral Vector Preparation for Efficient Gene and MicroRNA Modulation of Peritoneal Cavity Tissue-Resident Macrophages In Vivo in Mice

Published on: February 16, 2024

Related Concept Videos

Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...